Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Study Reveals "Unacceptable Delays" In Stroke Prevention Surgery
Only one in five UK patients have surgery to reduce their risk of stroke within the two week target time set by the National Institute for Health and Clinical Excellence (NICE), finds a study published on bmj.com today.
generic viagra online
Faculty Of Translational Medicine Boosts Support For Biomedical Researchers
A new Faculty of Translational Medicine has been launched to increase support for, and enhance collaboration among researchers as they search for new treatments and diagnostic tests for a range of diseases and conditions. The Faculty is based in the National Institute for Health Research Comprehensive Biomedical Research Center at Guy"s and St Thomas" hospitals and King"s College London.
News of the day
The Ozone Man Treats Xaverian High School To Prevent Spread Of Contaminated Swine Flu Within Its Indoor Environments
The Ozone Man, Inc. (OTCBB: OZOM), dba TOMI Environmental Solutions, or TOMIES, announced today the completion of a deep cleaning treatment of Xaverian High School with a student body of 1400 located in Brooklyn, New York. The Ozone Man"s treatment eliminated contaminants including Swine Flu "H1N1" along with inactivating viruses. The Ozone Man"s treatment also eliminates odor, mold spores and kills bacteria in the treated areas. Its proprietary Ultraviolet Ozone Generators produce the cleanest ozone south of the stratosphere, helping to ensure the health, safety and well being of the building and its inhabitants.
Endocrinology

FDA Reviewing Preliminary Safety Information On Asthma Drug Xolair

The U.S. Food and Drug Administration announced that it is conducting a safety review of Xolair (omalizumab), a drug used to treat certain adults and adolescents with moderate-to-severe persistent asthma. Reviewers are looking for a possible association between patients who use Xolair and an increased risk of heart attack, abnormal heart rhythm, heart failure, and stroke. The possible association has been identified based on interim results from an ongoing study of Xolair known as Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS). The study is being conducted by the manufacturer, San Francisco-based Genentech Inc. An FDA Early Communication is available online. The Early Communication is in keeping with the FDA"s commitment to inform the public about its ongoing safety reviews of drugs. Once its review is completed, the FDA will communicate its findings and any resulting recommendations to the public. Until the evaluation is completed, health care professionals and patients should be aware that the agency is reviewing data that may suggest a risk of adverse events. The FDA is not advising a change in prescribing or use of the drug. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009